Medical Device News Magazine

Zavation Medical Products Launches Cortical Screw – Latest Portfolio Addition

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

June 16, 2020

Zavation Medical Products has announced the launch of the Cortical Screw, a screw designed for use in the cortical bone as an extension of the Zavation Spinal System.

Zavation Medical Products notes the Cortical Screw is the latest addition to Zavation’s portfolio. The cortical screw is designed to achieve greater cortical bone purchase with a smaller midline incision when using Cortical Bone Trajectory (CBT). It comes in a variety of sizes to provide an optimized fit for each patient. It also includes a self-tapping feature on both sides of the tip and a 30 degree variable head angulation. This optimized fit allows for enhancement of structural stability while the thread design maximizes screw purchase. Standard and reduction screw options are offered and the reduction screw has a “break-off” tab available.

Dr. Graham Calvert, Orthopedic Spine Surgeon at Mississippi Sports Medicine, stated, “I am very excited about the new cortical screw technology from Zavation Medical Products. With 3 zones of variable thread pitch it is tailor-made for the cortical trajectory. The system is also extremely versatile with 4.5, 5.0, and 5.5mm diameter offerings. Overall it is the most compact, durable, and easy to implant cortical system on the market. I have been utilizing for over a year now with one hundred plus cases and have had no hardware failure.”

The Zavation Spinal System is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: degenerative disc disease (DDD) (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); spinal stenosis; tumor; pseudoarthrosis; and failed previous fusion.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”